Lab
Pain MD LLC
Pain MD LLC was paid $1.39M by Medicaid between Jan 2018 and May 2019, across 26 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 34% of everything it billed.
33Billing provider infoPAIN MD LLC
FRANKLIN, TN 37067
FRANKLIN, TN 37067
33aNPI1639509664assigned 11/12/2013
33bProvider typeClinical Medical Laboratory
28Total paid$1.39M
24GClaims62,134
24DCodes billed26
24AFirst – last monthJan 2018 – May 2019
Compared with peers
Next to other Clinical Medical Laboratory providers in Tennessee
Rank by total paid#23 of 70
Median peer was paid$141K
This provider vs. median9.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 56,862 | $1.10M | |
| 2019 | 5,272 | $286K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 34% | 15,652 | 11,472 | $466K |
| 20551 | 34% | 29,249 | 7,205 | $465K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 11% | 2,633 | 2,458 | $157K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 11% | 2,492 | 2,322 | $151K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.2% | 2,752 | 1,896 | $59K |
| 20553 | 2.4% | 1,582 | 1,115 | $33K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 2,151 | 1,416 | $16K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 160 | 141 | $13K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 98 | 84 | $7K |
| 20552 | <1% | 312 | 285 | $7K | |
| 20610 | <1% | 397 | 178 | $3K | |
| 80356 | <1% | 128 | 123 | $2K |
14 more codes
| 80361 | <1% | 130 | $2K | |
| 96161 | <1% | 406 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,197 | $1K |
| 80365 | <1% | 72 | $888.21 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 19 | $665.58 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 1,541 | $347.90 |
| 80346 | <1% | 13 | $256.88 | |
| 72100 | <1% | 17 | $230.33 | |
| L0180 | Cervical, multiple post collar, occipital/mandibular supports, adjustable | <1% | 18 | $200.50 |
| 80325 | <1% | 12 | $179.04 | |
| 80336 | <1% | 14 | $175.14 | |
| 80359 | <1% | 12 | $150.12 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 38 | $73.92 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 39 | $47.83 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOMBS, CARROLL (CORPORATE COUNSEL)
| Provider | Location | Paid |
|---|---|---|
| Pain MD LLC | Lawrenceburg, TN | $1K |
| Pain MD LLC | Kingsport, TN | $962.38 |
| Pain MD LLC | Tullahoma, TN | $462.02 |
| Pain MD LLC | Christiansburg, VA | $74.67 |
| Pain MD LLC | Mount Airy, NC | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.